- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2023–2025 · career development · K99
Investigating the interplay between senescence and T cell immunity
Riccardo Mezzadra · Kettering University · funded by National Institutes of Health
2023 · research · R35
The role of the intestinal microbiome in cancer immunotherapy
Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health
2023–2025 · research · R21
Genomics of Renal Cancer in Patients of African Ancestry
Alison M. Taylor · Kettering University · funded by National Institutes of Health
2023–2028 · career development · K08
Studies on Lineage Plasticity in Prostate Cancer
Samir Zaidi · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Nanosensor Array Platform to Capture Whole Disease Fingerprints
Daniel Alan Heller · Kettering University · funded by National Institutes of Health
2023–2025 · career development · K99
Mechanisms and vulnerabilities of ERG-driven luminal fate in prostate cancer
Weiran Feng · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
Michael Kharas · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2023–2024 · research · R56
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
Xiang Shu · Kettering University · funded by National Institutes of Health
2023–2024 · career development · K08
Targeting regenerative reprogramming in colorectal cancer
Salvador Alonso Martinez · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Phase 2 Bridging Pre-transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)
Joseph H Oved · Kettering University · funded by U.S. Food and Drug Administration
2023–2025 · research · R21
Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life
James H Flory · Kettering University · funded by National Institutes of Health
2023–2026 · research · R01
Deciphering the Acidic Tumor Environment: A Phase I/IIa Study of Pre-Operative Multiparametric MRI and pHLIP® ICG Intra-Operative Fluorescence Imaging of Primary Breast Cancer
Monica Morrow · Kettering University · funded by National Institutes of Health
2023–2025 · career development · K99
The role of the novel interface cell state in melanoma invasion
Miranda Victoria Hunter · Kettering University · funded by National Institutes of Health
2023–2026 · research · R00
New approaches for leveraging single-cell data to identify disease-critical genes and gene sets
Kushal Kumar Dey · Kettering University · funded by National Institutes of Health
2023–2028 · career development · K08
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells
Roni Shouval · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Nanosensor Array Platform to Capture Whole Disease Fingerprints
Daniel Alan Heller · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
TOX-driven CD8 T cell differentiation and dysfunction in tumors
Andrea Schietinger · Kettering University · funded by National Institutes of Health
2023–2024 · research · R03
Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy
Anthony Francis Yu · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)
Stephen Alan Sands · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Chemical Genetic Dissection of SWI/SNF Chromatin Remodeling Complex Functions in Cerebral Cortex Development
Thomas S Vierbuchen · Kettering University · funded by National Institutes of Health
2023–2026 · research · R37
The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention
Victoria S Blinder · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
Ming Li · Kettering University · funded by National Institutes of Health
2023–2027 · research · R37
Defining the function of Complex I truncating mutations in cancer
Payam Gammage · Kettering University · funded by National Institutes of Health
2023–2030 · research · R35
Exploring the Role of Nitrogen Metabolism in Cancer
Craig B Thompson · Kettering University · funded by National Institutes of Health
2023–2028 · career development · K08
Therapeutic targeting of RTK protein granules in cancer
Asmin Tulpule · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Germline mutagenesis at meiotic double-strand breaks
Maria Jasin · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of adaptation and resistance to emerging therapies for lung cancer
Piro Lito · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Autoimmune Stem-like CD8 T cells in Type 1 Diabetes
Andrea Schietinger · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Targeting plasticity in lung cancer
Tuomas Tammela · Kettering University · funded by National Institutes of Health
2023–2025 · research · R37
The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention
Victoria S Blinder · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
Christopher Austin Klebanoff · Kettering University · funded by National Institutes of Health
2023–2025 · research · R21
Molecular and cellular pathways driving competency for human vagal neural crest specification
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Molecular Glues to Target RAS-MAPK Driven Cancers
Arvin Dar · Kettering University · funded by National Institutes of Health
2023–2026 · research · R01
Origins and functions of pancreatic cancer-associated fibroblasts
Mara H. Sherman · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Cell Intrinsic and Extrinsic Factors Driving Maturation in Human PSC-derived Neurons
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
Ping Chi · Kettering University · funded by National Institutes of Health
2023 · research · R01
Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance
Margaret Kathleen Callahan · Kettering University · funded by National Institutes of Health
2023–2028 · career development · K08
Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer
Adam Widman · Kettering University · funded by National Institutes of Health